BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22052141)

  • 1. Povidone-iodine and bleomycin in the management of malignant pleural effusion.
    Alavi AA; Eshraghi M; Rahim MB; Meysami AP; Morteza A; Hajian H
    Acta Med Iran; 2011; 49(9):584-7. PubMed ID: 22052141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
    Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
    J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodopovidone pleurodesis: experience of a tertiary hospital in Kolkata.
    Dey A; Bhuniya S; Datta Chaudhuri A; Pandit S; Saha-Dutta Chowdhury M; Sengupta A; Saha I; De P
    Singapore Med J; 2010 Feb; 51(2):163-5. PubMed ID: 20358157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial.
    Mohsen TA; Zeid AA; Meshref M; Tawfeek N; Redmond K; Ananiadou OG; Haj-Yahia S
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):282-6. PubMed ID: 20961772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of iodopovidone versus bleomycin in chemical pleurodesis.
    Bagheri R; Noori M; Rajayi M; Attaran D; Mohammad Hashem Asna Ashari A; Mohammadzadeh Lari S; Basiri R; Rezaeetalab F; Afghani R; Salehi M
    Asian Cardiovasc Thorac Ann; 2018 Jun; 26(5):382-386. PubMed ID: 29792037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms.
    Kelly-Garcia J; Roman-Berumen JF; Ibarra-Perez C
    Arch Med Res; 1997; 28(4):583-5. PubMed ID: 9428588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
    Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
    J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions.
    Neto JD; de Oliveira SF; Vianna SP; Terra RM
    Respirology; 2010 Jan; 15(1):115-8. PubMed ID: 19947987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions.
    Zimmer PW; Hill M; Casey K; Harvey E; Low DE
    Chest; 1997 Aug; 112(2):430-4. PubMed ID: 9266880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pleurodesis in malignant pleural effusion: bleomycin vs. mitoxantrone].
    Schmidt M; Schaarschmidt G; Chemaissani A
    Pneumologie; 1997 Apr; 51(4):367-72. PubMed ID: 9221383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube.
    Caglayan B; Torun E; Turan D; Fidan A; Gemici C; Sarac G; Salepci B; Kiral N
    Ann Surg Oncol; 2008 Sep; 15(9):2594-9. PubMed ID: 18594928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleomycin and tetracycline in malignant pleural effusions: a review.
    Moffett MJ; Ruckdeschel JC
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):59-62; discussion 62-3. PubMed ID: 1384146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleurodesis with povidone iodine in patients with malignant pleural effusion in a tertiary center in Nigeria.
    Omoregbee BI; Okugbo S
    Pan Afr Med J; 2021; 38():169. PubMed ID: 33995776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intracavitary treatment of malignant pleural effusion with iodine-povidone].
    Echavarría A; Pinzón V; Barés JP; Fernández E
    Rev Med Panama; 1991 Jan; 16(1):69-74. PubMed ID: 2024059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleurodesis with povidone-iodine, as an effective procedure in management of patients with malignant pleural effusion.
    Godazandeh G; Qasemi NH; Saghafi M; Mortazian M; Tayebi P
    J Thorac Dis; 2013 Apr; 5(2):141-4. PubMed ID: 23585939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
    Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
    Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions.
    Hartman DL; Gaither JM; Kesler KA; Mylet DM; Brown JW; Mathur PN
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):743-7; discussion 747-8. PubMed ID: 7682268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleomycin in malignant pleural effusion. Choose talc pleurodesis.
    Prescrire Int; 2011 Dec; 20(122):291. PubMed ID: 22216541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small chest-tube drainage followed by bleomycin sclerosis for malignant pleural effusions.
    Goff BA; Mueller PR; Muntz HG; Rice LW
    Obstet Gynecol; 1993 Jun; 81(6):993-6. PubMed ID: 7684517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Povidone-iodine chemical pleurodesis in treating spontaneous chylothorax in pediatric patients.
    Long WG; Cai B; Liu Y; Wang WJ
    Ann Palliat Med; 2020 May; 9(3):1004-1012. PubMed ID: 32434361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.